AGTR1 and breast carcinoma: Downstream activation of the AT1 receptor in breast cancer cells, triggers CBM/NF-κB-mediated inflammatory response by releasing inflammatory cytokines and growth factors including IL-1β, IL-8, IL6, and VEGF to the microenvironment [213, 214].